Global Health Outcomes, Inc. examines the Personal Medicine Report.

Dec. 2, 2008 - PRLog -- The U.S. Department of Health and Human Services, which spends an estimated $700 billion per year on providing healthcare services to over 80 million individuals, recently released its second personalized medicine report as a driver for reforming the $2 trillion U.S. healthcare system. The report is available at http://www.hhs.gov/myhealthcare/news/phc_2008_report.pdf.

The comprehensive report provided various statistics and illustrations to justify the need to adopt personalized medicine as a driver for improving health outcomes and reforming the healthcare system.

For example, the report noted that although we have developed powerful pharmaceuticals – most drugs prescribed in the United States today are effective in fewer than 60 percent of treated patients. Thus creating a challenge to predict and measure patient health outcomes as well as improve the healthcare system, which is projected to double from $2 trillion to $4 trillion in the next decade.

HHS Secretary Leavitt indicated in a Bloomberg article that the new incoming Obama Administration may want to consider findings in the reports as it debates overhauling and/or expanding access to healthcare. (See http://www.bloomberg.com/apps/news?pid=20601124&sid=aHJaV...#)

“Global Health Outcomes, Inc. strongly believes that all parties involved in the U.S. healthcare system will need predictable, actuarial, and economically sound tools to measure and evaluate health outcomes.  We are in the process of developing disease-based indices that will measure the performance of the $2 trillion healthcare system via health outcomes. Current indexes used by HHS, such as the Consumer Price Index, Produce Price Index, and the Medical Expenditure Index, albeit robust, are broad in scope and not geared towards measuring health outcomes,” said Efthimi Parasidis, the company’s Vice President and Chief Legal Officer.

Javaid Zafar, the company’s President and Chief Strategy Officer added, “Our first index to be introduced will be the Diabetes Health Outcomes Index. This index universe is being tested and will include a substantial level of diabetes data.”  With 25 million Americans being treated for diabetes - 6 million of whom are Medicare beneficiaries - and consuming $116 billion per year, personalized medicine appears to be a sound solution for improving healthcare. Nevertheless, to determine if such strategies are in effect improving health outcomes, Global Health Outcomes seeks to provide an independent and predictable instrument which the system can use to accurately measure health outcomes.

# # #

About Global Health Outcomes, Inc.

Global Health Outcomes, Inc. is a start-up company that is developing disease-based indices that the complex $2 Trillion healthcare market can rely on to make accurate investment decisions. The privately held company is headquartered in New York, with product development offices in Chicago.